3D Molecular Sciences Ltd |
E.M. Warburg, Pincus & Co. International Earlybird Venture Capital GmbH & Co. KG Eckert & Ziegler AG Eisai GmbH Eli Lily & Co Ernst & Young AG ESBATech AG Euro am Sonntag EuroProteome AG Extorel Private Equity Advisers GmbH Financial Times Deutschland FOCUS Clinical Drug Development GmbH Focus Inhalation Oy Focus Money Forum Venture Capital AG Frankfurter Allgemeine Sonntagszeitung G.O.T. Therapeutics GmbH G2M AG Gamida Cell Ltd. Ganymed Pharmaceuticals AG GATX ETV Genopia Biomedical GmbH GENOVAC AG GenoVoxx GmbH GenPat77 Pharmacogenetics AG Genzyme GmbH German Association of Biotechnology Industries (DIB) Gilde Investment Management GIMV GlaxoSmithKline Global Life Science Ventures GmbH GLYCART biotechnology AG GoingPublic Media AG Greater Zurich Area AG Haarmann Hemmelrath & Partner HAEMATO-basics GmbH Harrison Clinical Research HBM Partners AG HCC De Facto Healthcare Zentrum HSBC Hugin IR Services Deutschland GmbH HypoVereinsbank AG IBM Deutschland GmbH Immunicon Corporation Imperial College Innovations Imperial College of Science, Technology and Medicine Infineon Ventures BioChip Infineon Ventures GmbH ING Barings INSEAD Healthcare Management Initiative Intercell AG investorsmedia AG InVivo Europe RX IonGate Biosciences GmbH Isogenica Ltd IsoTis NV JPMorgan Partners Juvantia Pharma Ltd Karolinska Innovations AB Katan Associates Kayenburg AG Kirchhoff Consult AG Kirchhoff Equity Consult GmbH KPMG KPMG Beiten Burkhardt Landesbank Baden-Württemberg Lehman Brothers Ltd Limburg Development Company London Stock Exchange Lorantis Ltd Lynkeus BioTech GmbH mbt Munich Biotechnology AG Medichip Medigene AG Mediport Venture GmbH Merlin Bioscience Micromet AG Morgan, Lewis & Bockius LLP MPM Capital GmbH Mulligan BioCapital AG MWG-Biotech AG NanoCyte Inc. |
NascaCell GmbH Nature Publishing Group NEMOD Immuntherapie AG NMT Management AG NMT New Medical Technologies Management AG Noonan Russo Presense Euro RSCG Novartis Pharma AG NovaSpin Biotech GmbH Novo A/S NV Industriebank LiDF O & R Corporate Finance Beratungsgesellschaft GmbH OPTIMAL OFFICE OSI Pharmaceuticals Oxford Bioscience Partners Oxford GlycoSciences PamGene International BV PanTherix Ltd. Paratek Pharmaceuticals, Inc. Parigi Equity Partners srl Paul Capital Partners Pep-Per BioTech GmbH Peppermint PharmaDM Pharmalicensing Ltd Pharmaprojects Pharming Group N.V. PIERIS Proteolab AG Proneuron Biotechnologies, Inc. ProSkelia r.toder.consulting Reuters RiboTargets Ltd Ruston Poole International SangStat Medical Corp ScheBo Biotech AG Scimagix, Inc. Scottish Equity Partners Scrip Reports Seed GmbH Selvaag Venture Capital Senetek PLC Sense Proteomic Ltd Serono International S.A. Siemens Simile Partners LLC SiREEN AG SJ Berwin Knopp Tulloch Steininger Sloning Biotechnology GmbH Sofinnova Partners Solexa Ltd. Solvias AG Solving International State of Indiana (USA) SÜD Venture Capital GmbH Suterscience SWX Swiss Exchange Sympore GmbH SynaptB.R.A.H.M.S Aktiengesellschaftica Ltd Targa Therapies S.A. Target Discovery, Inc. Taylor Nelson Sopres Healthcare Techno Venture Management The e-Firm The Entrepreneurial Group e.V. The Genetics Company, Inc. TRACE Biotech AG TRB AG Triad Therapeutics Trigen, Ltd. TVM Techno Venture Management UBS Warburg University of Cambridge University of Tübingen Clinic Vasopharm BIOTECH Ventech Venture Valuation VV AG VI Partners AG Vogel BioConsulting VWD Warburg Pincus Weitnauer Rechtsanwälte WestLB Panmure Windhover Information Inc Xantos Biomedicine AG Xerion Pharmaceuticals AG |